✦ LIBER ✦

Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

✍ Scribed by Eva J Kantelhardt; Martina Vetter; Marcus Schmidt; Corinne Veyret; Doris Augustin; Volker Hanf; Christoph Meisner; Daniela Paepke; Manfred Schmitt; Fred Sweep; Gunter von Minckwitz; Pierre-Marie Martin; Fritz Jaenicke; Christoph Thomssen; Nadia Harbeck

Book ID: 115010349
Publisher: BioMed Central
Year: 2011
Tongue: English
Weight: 292 KB
Volume: 11
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-11-140

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NNBC-3 Europe study: a trial to improve

NNBC-3 Europe study: a trial to improve risk estimation and risk adapted adjuvant chemotherapy in node negative breast cancer patients by using new uPA and PAI-1 and to analise the efficacy of a sequential FEC-taxane chemotherapy versus a standard FEC-chemotherapy regimen

✍ F Herbst; N Harbeck; V.P.R Mueller; A Oben; C Meisner; F Sweep; M Schmitt; F Jae 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 171 KB